Skip to main content
. 2020 Jul 15;59(14):1677–1685. doi: 10.2169/internalmedicine.4399-19

Table 2.

Association between the Likelihood of Frailty in Univariate Analysis.

Covariates Non-Frailty Group
242 subjects
(77.3%)*
Frailty Group
71 subjects
(22.7%)*
p value
Patient profile
Age (years) 74.4 (±5.7)** 80.0 (±5.0)** <0.001
Gender
Male 113 (46.7)* 21 (29.6)*
Female 129 (53.3)* 50 (70.4)* 0.010
BMI (kg/m2) 23.0 (±3.6)** 22.0 (±3.3)** 0.050
Helicobacter pylori infection status
Helicobacter pylori infection
negative 125 (51.6)* 43 (60.6)*
positive 52 (21.5)* 17 (23.9)* 0.661
successful eradication 65 (26.9)* 11 (15.5)* 0.049
Internal medicine therapeutic agents
Proton pump inhibitor (PPI)
non-user 164 (67.8)* 31 (43.7)*
user 78 (32.2)* 40 (56.3)* <0.001
Aspirin
non-user 222 (91.7)* 62 (87.3)*
user 20 (8.3)* 9 (12.7)* 0.260
Laxative/Prokinetics
non-user 196 (81.0)* 47 (66.2)*
user 46 (19.0)* 24 (33.8)* 0.008
Comorbidity
Sarcopenia
no 211 (87.2)* 30 (42.3)*
yes 31 (12.8)* 41 (57.7)* <0.001
Osteoporosis
no 163 (67.4)* 25 (35.2)*
yes 79 (32.6)* 46 (64.8)* <0.001
Nutritional status
Zinc (µg/dL) 74.3 (±11.9)** 69.6 (±9.6)** 0.002
Albumin (g/dL) 4.2 (±0.3)** 4.0(±0.4)** <0.001
Cholesterol (mg/dL) 205 (±34)** 199 (±41)** 0.272
Lymphocyte (counts/µL) 1,898 (±610)** 1,662 (±584)** 0.004
CONUT score 0.7 (±1.0)** 1.3 (±1.4)** <0.001
Upper GI Findings
Reflux esophagitis (RE)
no 222 (91.3)* 67 (94.4)*
yes 21 (8.7)* 4 (5.6)* 0.405
Hiatal hernia (HH)
no 121 (50.0)* 27 (38.0)*
yes 121 (50.0)* 44 (62.0)* 0.076
Endoscopic gastric mucosal atrophy score (EGAS) 2.5 (±2.0)** 2.9 (±2.1)** 0.164
Questionnaire
FSSG 4.3 (±5.0)** 6.7 (±7.0)** 0.001
CSS 3.4 (±3.4)** 6.2 (±5.6)** <0.001
BSFS 4.0 (±1.0)** 4.0 (±1.3)** 0.903

* Number (%), ** Median (±SD). FSSG: Frequency Scale for Symptoms of Gastroesophageal Reflux Disease, CSS: Constipation Scoring System, BSFS: Bristol Stool Form Scale